2012		2013		2014		Rate (Cases per 100,000 per quarter)		Quarterly Rate Comparison
Disease	Q1 No.	YTD No.	Q1 No.	YTD No.	Q1 No.	YTD No.	Q1 (2008-2012 aggregated)	Q1 (2013)	Significant change bet. current & past 5-year?~~
Vaccine Preventable
Diphtheria	0	0	0	0	0	0	0.00	0.00
Haemophilus Influenza (Invasive)	.	.	.	.	.	.	0.22	0.20
Hepatitis A	.	.	.	.	.	.	0.11	0.05
Hepatitis B (Acute)	10	10	8	8	.	.	0.38	0.15
Influenza**	192	192	455	455	381	381	13.81	18.85	X
Measles	0	0	0	0	0	0	0.01	0.00
Mumps	0	0	0	0	0	0	0.00	0.00
Pertussis	8	8	26	26	13	13	0.37	0.64
Poliomyelitis	0	0	0	0	0	0	0.00	0.00
Rubella	0	0	0	0	0	0	0.00	0.00
Tetanus	0	0	0	0	0	0	0.00	0.00
Sexually Transmitted
AIDS	58	58	55	55	46	46	2.78	2.28
Chlamydia	2228	2228	2215	2215	2096	2096	110.85	103.70	X
Gonorrhea	407	407	535	535	487	487	23.56	24.09
HIV	65	65	62	62	54	54	3.14	2.67
Syphilis (Early Latent)	46	46	66	66	58	58	2.30	2.87
Syphilis (Primary & Secondary)	20	20	29	29	52	52	1.19	2.57	X
Enterics
Amebiasis	.	.	.	.	0	0	0.10	0.00	X
Botulism-Intestinal (Infant)	0	0	0	0	0	0	0.00	0.00
Campylobacteriosis	18	18	15	15	22	22	1.15	1.09
Cholera	0	0	0	0	0	0	0.00	0.00
Cryptosporidiosis	.	.	.	.	0	0	0.04	0.00
Giardia	12	12	11	11	.	.	0.65	0.20	X
Rotavirus	.	.	38	38	7	7	0.68	0.35
Salmonellosis	24	24	29	29	15	15	1.32	0.74
Shiga-Toxin Producing E. Coli#	12	12	6	6	.	.	0.39	0.15
Shigellosis	.	.	10	10	.	.	0.41	0.15
Typhoid Fever	0	0	0	0	0	0	0.01	0.00
Vibrio (Non-Cholera)	0	0	0	0	.	.	0.00	0.05
Yersiniosis	.	.	.	.	.	.	0.03	0.05
Other
Anthrax	0	0	0	0	0	0	0.00	0.00
Botulism Intoxication	0	0	0	0	0	0	0.00	0.00
Brucellosis	0	0	0	0	0	0	0.00	0.00
Coccidioidomycosis	33	33	15	15	15	15	1.05	0.74
Dengue Fever	0	0	.	.	0	0	0.02	0.00
Encephalitis	0	0	.	.	0	0	0.02	0.00
Hantavirus	0	0	0	0	0	0	0.00	0.00
Hemolytic Uremic Syndrome (HUS)	0	0	0	0	0	0	0.01	0.00
Hepatitis C (Acute)	.	.	0	0	0	0	0.07	0.00	X
Hepatitis D	0	0	0	0	0	0	0.00	0.00
Invasive Group A Strep.##	0	0	0	0	0	0	0.11	0.00	X
Legionellosis	.	.	.	.	.	.	0.17	0.05
Leprosy (Hansen’s Disease)	0	0	0	0	0	0	0.01	0.00
Leptospirosis	0	0	0	0	0	0	0.00	0.00
Listeriosis	.	.	.	.	0	0	0.03	0.00
Lyme Disease	.	.	0	0	0	0	0.02	0.00
Malaria	.	.	.	.	0	0	0.04	0.00
Meningitis, Aseptic/Viral	.	.	5	5	6	6	0.33	0.30
Meningitis, Bacterial	.	.	.	.	.	.	0.09	0.20
Meningococcal Disease	.	.	0	0	.	.	0.05	0.10
Plague	0	0	0	0	0	0	0.00	0.00
Psittacosis	0	0	0	0	0	0	0.00	0.00
Q Fever	0	0	0	0	0	0	0.00	0.00
Rabies (Human)	0	0	0	0	0	0	0.00	0.00
Relapsing Fever	0	0	0	0	0	0	0.00	0.00
Rocky Mountain Spotted Fever	0	0	0	0	0	0	0.00	0.00
RSV (Respiratory Syncytial Virus)	685	685	1077	1077	475	475	43.32	23.50	X
Streptococcus Pneumoniae, IPD###	18	18	20	20	23	23	0.81	1.14
Toxic Shock Syn	0	0	0	0	0	0	0.01	0.00
Toxic Shock Syn (Streptococcal)	.	.	.	.	.	.	0.03	0.20
Tuberculosis	22	22	18	18	12	12	0.92	0.59
Tularemia	0	0	0	0	0	0	0.00	0.00
Unusual Illness	0	0	0	0	0	0	0.01	0.00
West Nile Virus (Encephalitis)	0	0	0	0	0	0	0.00	0.00
West Nile Virus (Fever)	0	0	0	0	0	0	0.00	0.00

*Rate denominators were spline-interpolated population estimates/projections based on demographic data subject to ongoing revision by the state demographer (last revision as of Oct-2013). Use of onset date to count OOE-reported cases (since Ja including confirmed, probable and suspect (since Feb-08) cases. HIV/AIDS case counts provided by Office of HIV/AIDS/STD; TB case counts provided by TB clinic. Data suppression denoted by ‘.’ applies if number of cases <5. Quarterly disease total reported by OOE=988(reported total=3793). Due to unavailability of current birth data, congenital syphilis rates were not calculated(reported quarterly cases [suppression applied] for 2012-2014 were respectively 0,.,.; YTD totals 0,.,.).

**Reporting of novel type A influenza (reclassified as INFLU OUTBRK per CDC recommendations as of Jan-11) started in May-09.

#E. COLI 0157:H7 instead of STEC was reported prior to 2006.

##Reported since Mar-07.

###S. pneumo invasive diseases (reported since Sep-05) previouly reported under separate categories grouped together as of Jan-11 per CDC recommendations.

~~Confidence intervals (not shown) for the quarterly disease incidence rates provided a basis for an informal statistical test to determine if the current quarterly rates changed significantly from those of the previous 5 years aggregated. Text in green where rates decreased and in red where rates increased. Statistically significant changes indicated by ‘X’ (rate comparisons made if 5+ cases reported in the current quarter of this year or previous 5 years aggregated).